BE Study of Calcipotriene Hydrate and Betamethasone Dipropionate Topical Suspension in the Treatment of Scalp Psoriasis
Public ClinicalTrials.gov record NCT03122353. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind Study Comparing TOLMAR Calcipotriene and Betamethasone Suspension to Reference Listed Drug in the Treatment of Scalp Psoriasis
Study identification
- NCT ID
- NCT03122353
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1
- Lead sponsor
- Tolmar Inc.
- Industry
- Enrollment
- 699 participants
Conditions and interventions
Conditions
Interventions
- Calcipotriene and betamethasone suspension Drug
- Taclonex Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 10, 2017
- Primary completion
- Nov 14, 2017
- Completion
- Nov 14, 2017
- Last update posted
- Mar 6, 2018
2017
United States locations
- U.S. sites
- 34
- U.S. states
- 16
- U.S. cities
- 31
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Site 17 | Hot Springs | Arkansas | 71913 | — |
| Site 29 | Fremont | California | 94538 | — |
| Site 12 | Los Angeles | California | 90036 | — |
| Site 18 | Sherman Oaks | California | 91403 | — |
| Site 34 | Denver | Colorado | 80220 | — |
| Site 20 | Boca Raton | Florida | 33486 | — |
| Site 01 | Brandon | Florida | 33511 | — |
| Site 25 | Coral Gables | Florida | 33134 | — |
| Site 11 | Hialeah | Florida | 33012 | — |
| Site 26 | Miami | Florida | 33126 | — |
| Site 04 | Miami | Florida | 33175 | — |
| Site 05 | Miramar | Florida | 33027 | — |
| Site 02 | Tampa | Florida | 33609 | — |
| Site 03 | Tampa | Florida | 33618 | — |
| Site 23 | Winter Park | Florida | 32792 | — |
| Site 16 | Plainfield | Indiana | 46168 | — |
| Site 19 | Olathe | Kansas | 66061 | — |
| Site 33 | Lake Charles | Louisiana | 70601 | — |
| Site 27 | Saint Joseph | Missouri | 64506 | — |
| Site 14 | Las Vegas | Nevada | 89106 | — |
| Site 09 | High Point | North Carolina | 27262 | — |
| Site 28 | Hazleton | Pennsylvania | 18201 | — |
| Site 24 | Upper Saint Clair | Pennsylvania | 15241 | — |
| Site 32 | Johnston | Rhode Island | 02919 | — |
| Site 07 | Anderson | South Carolina | 29621 | — |
| Site 35 | Mt. Pleasant | South Carolina | 29464 | — |
| Site 21 | Austin | Texas | 78759 | — |
| Site 06 | Dallas | Texas | 75234 | — |
| Site 30 | El Paso | Texas | 79902 | — |
| Site 08 | Murphy | Texas | 75094 | — |
| Site 15 | San Antonio | Texas | 78229 | — |
| Site 31 | San Antonio | Texas | 78229 | — |
| Site 10 | Salt Lake City | Utah | 84117 | — |
| Site 22 | Norfolk | Virginia | 23507 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03122353, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 6, 2018 · Synced Jul 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03122353 live on ClinicalTrials.gov.